Intersection of http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution and http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution

This is the CodeSystem that contains codes in both Substance Admin Substitution (http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution) and Substance Admin Substitution (http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution).

Structure

Generated Narrative: CodeSystem c5ecab15-a0f9-4fdf-9d87-bde1e84b2f11-2625

Properties

This code system defines the following properties for its concepts

NameCodeURITypeDescription
Not SelectablenotSelectablehttp://hl7.org/fhir/concept-properties#notSelectablebooleanIndicates that the code is abstract - only intended to be used as a selector for other concepts
Statusstatushttp://hl7.org/fhir/concept-properties#statuscodeDesignation of a concept's state. Normally is not populated unless the state is retired.
Not SelectablenotSelectablehttp://hl7.org/fhir/concept-properties#notSelectablebooleanIndicates that the code is abstract - only intended to be used as a selector for other concepts
Statusstatushttp://hl7.org/fhir/concept-properties#statuscodeDesignation of a concept's state. Normally is not populated unless the state is retired.

Concepts

This code system http://hl7.org/fhir/comparison/CodeSystem/c5ecab15-a0f9-4fdf-9d87-bde1e84b2f11-2625 defines codes in an undefined hierarchy, but no codes are represented here

LvlCodeDisplayDefinitionNot SelectableStatusNot SelectableStatus
1_ActSubstanceAdminSubstitutionCode ActSubstanceAdminSubstitutionCode

Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects.

true, trueactive, activetrue, trueactive, active
2  E equivalent

Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.

activeactive
3    EC equivalent composition

Substitution occurred or is permitted with another product that is a:

  • pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester
  • pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration

Examples:

  • Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate
  • Pharmaceutical equivalent: Lisonpril for Zestril
activeactive
4      BC brand composition

Substitution occurred or is permitted between equivalent Brands but not Generics

Examples:

  • Zestril for Prinivil
  • Coumadin for Jantoven
activeactive
4      G generic composition

Substitution occurred or is permitted between equivalent Generics but not Brands

Examples:

  • Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)
activeactive
3    TE therapeutic alternative

Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile.

Examples:

  • ranitidine for Tagamet
activeactive
4      TB therapeutic brand

Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics

Examples:

  • Zantac for Tagamet
activeactive
4      TG therapeutic generic

Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands

Examples:

  • Ranitidine for cimetidine
activeactive
2  F formulary

This substitution was performed or is permitted based on formulary guidelines.

activeactive
2  N none

No substitution occurred or is permitted.

activeactive
2  E equivalent

Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.

active, activeactive, active
3    EC equivalent composition

Substitution occurred or is permitted with another product that is a:

  • pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester
  • pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration

Examples:

  • Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate
  • Pharmaceutical equivalent: Lisonpril for Zestril
activeactive
4      BC brand composition

Substitution occurred or is permitted between equivalent Brands but not Generics

Examples:

  • Zestril for Prinivil
  • Coumadin for Jantoven
activeactive
4      G generic composition

Substitution occurred or is permitted between equivalent Generics but not Brands

Examples:

  • Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)
activeactive
3    TE therapeutic alternative

Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile.

Examples:

  • ranitidine for Tagamet
activeactive
4      TB therapeutic brand

Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics

Examples:

  • Zantac for Tagamet
activeactive
4      TG therapeutic generic

Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands

Examples:

  • Ranitidine for cimetidine
activeactive
3    EC equivalent composition

Substitution occurred or is permitted with another product that is a:

  • pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester
  • pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration

Examples:

  • Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate
  • Pharmaceutical equivalent: Lisonpril for Zestril
active, activeactive, active
4      BC brand composition

Substitution occurred or is permitted between equivalent Brands but not Generics

Examples:

  • Zestril for Prinivil
  • Coumadin for Jantoven
activeactive
4      G generic composition

Substitution occurred or is permitted between equivalent Generics but not Brands

Examples:

  • Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)
activeactive
4      BC brand composition

Substitution occurred or is permitted between equivalent Brands but not Generics

Examples:

  • Zestril for Prinivil
  • Coumadin for Jantoven
active, activeactive, active
4      G generic composition

Substitution occurred or is permitted between equivalent Generics but not Brands

Examples:

  • Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)
active, activeactive, active
3    TE therapeutic alternative

Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile.

Examples:

  • ranitidine for Tagamet
active, activeactive, active
4      TB therapeutic brand

Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics

Examples:

  • Zantac for Tagamet
activeactive
4      TG therapeutic generic

Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands

Examples:

  • Ranitidine for cimetidine
activeactive
4      TB therapeutic brand

Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics

Examples:

  • Zantac for Tagamet
active, activeactive, active
4      TG therapeutic generic

Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands

Examples:

  • Ranitidine for cimetidine
active, activeactive, active
2  F formulary

This substitution was performed or is permitted based on formulary guidelines.

active, activeactive, active
2  N none

No substitution occurred or is permitted.

active, activeactive, active